These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 29788883)

  • 1. Models of Drug Induced Liver Injury (DILI) - Current Issues and Future Perspectives.
    Kuna L; Bozic I; Kizivat T; Bojanic K; Mrso M; Kralj E; Smolic R; Wu GY; Smolic M
    Curr Drug Metab; 2018; 19(10):830-838. PubMed ID: 29788883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current limitations and future opportunities for prediction of DILI from in vitro.
    Funk C; Roth A
    Arch Toxicol; 2017 Jan; 91(1):131-142. PubMed ID: 27766365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of urine proteomics for biomarker discovery in drug-induced liver injury.
    van Swelm RP; Kramers C; Masereeuw R; Russel FG
    Crit Rev Toxicol; 2014 Nov; 44(10):823-41. PubMed ID: 25264586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating mitochondrial biomarkers for drug-induced liver injury.
    Shi Q; Yang X; Mattes WB; Mendrick DL; Harrill AH; Beger RD
    Biomark Med; 2015; 9(11):1215-23. PubMed ID: 26507261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for drug-induced liver injury.
    Shi Q; Hong H; Senior J; Tong W
    Expert Rev Gastroenterol Hepatol; 2010 Apr; 4(2):225-34. PubMed ID: 20350268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man.
    Dragovic S; Vermeulen NP; Gerets HH; Hewitt PG; Ingelman-Sundberg M; Park BK; Juhila S; Snoeys J; Weaver RJ
    Arch Toxicol; 2016 Dec; 90(12):2979-3003. PubMed ID: 27659300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic approaches in the discovery of potential urinary biomarkers of drug-induced liver injury (DILI).
    Araújo AM; Carvalho M; Carvalho F; Bastos ML; Guedes de Pinho P
    Crit Rev Toxicol; 2017 Sep; 47(8):633-649. PubMed ID: 28436314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
    Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
    Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: drug-induced liver injury in clinical practice.
    Björnsson E
    Aliment Pharmacol Ther; 2010 Jul; 32(1):3-13. PubMed ID: 20374223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of novel tools for the in vitro investigation of drug-induced liver injury.
    Jiang J; Wolters JE; van Breda SG; Kleinjans JC; de Kok TM
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1523-37. PubMed ID: 26155718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced liver injury and drug development: industry perspective.
    Regev A
    Semin Liver Dis; 2014 May; 34(2):227-39. PubMed ID: 24879986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hopes and challenges in using miRNAs as translational biomarkers for drug-induced liver injury.
    Shi Q; Yang X; Mendrick DL
    Biomark Med; 2013 Apr; 7(2):307-15. PubMed ID: 23547824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-silico approach for drug induced liver injury prediction: Recent advances.
    Saini N; Bakshi S; Sharma S
    Toxicol Lett; 2018 Oct; 295():288-295. PubMed ID: 29981923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury.
    Thakkar S; Chen M; Fang H; Liu Z; Roberts R; Tong W
    Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):31-38. PubMed ID: 28931315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into mechanisms and severity of drug-induced liver injury via computational systems toxicology approach.
    Peng Y; Wu Z; Yang H; Cai Y; Liu G; Li W; Tang Y
    Toxicol Lett; 2019 Sep; 312():22-33. PubMed ID: 31063831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
    Liu Z; Shi Q; Ding D; Kelly R; Fang H; Tong W
    PLoS Comput Biol; 2011 Dec; 7(12):e1002310. PubMed ID: 22194678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-Induced Liver Injury and Individual Cell Models.
    Benesic A; Gerbes AL
    Dig Dis; 2015; 33(4):486-91. PubMed ID: 26159263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
    Eun JW; Bae HJ; Shen Q; Park SJ; Kim HS; Shin WC; Yang HD; Jin CY; You JS; Kang HJ; Kim H; Ahn YM; Park WS; Lee JY; Nam SW
    J Appl Toxicol; 2015 Feb; 35(2):152-64. PubMed ID: 25231249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of hepatic transcriptome profiling between acute liver injury and acute liver failure induced by acetaminophen in mice.
    Li C; Ming Y; Hong W; Tang Y; Lei X; Li X; Mao Y
    Toxicol Lett; 2018 Feb; 283():69-76. PubMed ID: 29174983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced liver injury.
    Leise MD; Poterucha JJ; Talwalkar JA
    Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.